Santa Fe, NM, United States of America

Simon J Perkins


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Santa Fe, NM (US) (2011)
  • Los Alamos, NM (US) (2012 - 2016)
  • Boulder, CO (US) (2018)

Company Filing History:


Years Active: 2011-2018

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Simon J Perkins

Introduction

Simon J Perkins is a notable inventor based in Santa Fe, NM (US), recognized for his significant contributions to the field of immunology. He holds a total of five patents, showcasing his dedication to advancing medical science and technology.

Latest Patents

Among his latest patents is the development of mosaic HIV envelope immunogenic polypeptides. This innovation aims to elicit an immune response to HIV, including cytotoxic T cell, helper T cell, and humoral responses. The patent also includes methods for treating or inhibiting HIV in subjects, which involves administering the disclosed immunogenic polypeptides or compositions to individuals infected with or at risk of HIV infection. Another significant patent involves nucleic acids encoding mosaic HIV-1 gag proteins, which relates to a polyvalent immunogenic composition, such as a polyvalent HIV vaccine, and methods of using it.

Career Highlights

Simon J Perkins has worked with prestigious institutions, including Duke University and Los Alamos National Security, LLC. His work in these organizations has contributed to his expertise and the development of his innovative patents.

Collaborations

Throughout his career, Perkins has collaborated with esteemed colleagues, including James Theiler and Bette T Korber. These partnerships have likely enhanced his research and development efforts in the field of immunology.

Conclusion

Simon J Perkins exemplifies the spirit of innovation in the medical field, particularly in the fight against HIV. His patents and collaborations reflect a commitment to improving health outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…